Delek US director plans $142K stock sale

Delek US Holdings, Inc. (DK) is the issuer of common stock covered by a notice of proposed sale filed for the account of director Richard J. Marcogliese.

Rhea-AI Filing Summary

Delek US Holdings, Inc. (DK) is the issuer of common stock covered by a notice of proposed sale filed for the account of director Richard J. Marcogliese. The notice covers a proposed sale of 2,000 shares of Delek US common stock through UBS Financial Services on the NYSE, with an aggregate market value of $142,100.00 based on the referenced price. The filing states that Delek US had 61,232,174 shares outstanding of common stock and lists an approximate sale date of August 21, 2026.

Key Figures

Shares proposed for sale: 2,000 shares of common stock Aggregate market value: $142,100.00 Shares outstanding: 61,232,174 shares +3 more

6 metrics

Shares proposed for sale 2,000 shares of common stock Proposed sale under Rule 144 for director Richard J. Marcogliese

Aggregate market value $142,100.00 Aggregate market value of 2,000 Delek US common shares referenced in the notice

Shares outstanding 61,232,174 shares Delek US Holdings, Inc. common stock outstanding as stated in the notice

Approximate sale date 08/21/2026 Approximate date of proposed sale on the NYSE

Open market purchase 1,000 shares on 12/11/2019 Common stock acquired for cash

Open market purchase 1,000 shares on 12/30/2019 Common stock acquired for cash

Key Terms

Rule 144, aggregate market value, open market purchase, securities to be sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Common Stock | UBS Financial Services ... | 2000 | 142100.00 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

open market purchase financial

"Common Stock | 12/11/2019 | Open Market Purchase | Open Market |"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

securities to be sold financial

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Delek US Holdings, Inc. (DK) disclose?

It discloses that director Richard J. Marcogliese has filed a notice of proposed sale under Rule 144 for up to 2,000 shares of Delek US Holdings, Inc. common stock, to be sold through UBS Financial Services on the NYSE around August 21, 2026.

How many Delek US Holdings, Inc. (DK) shares are covered by this Form 144?

The notice covers a proposed sale of 2,000 shares of Delek US Holdings, Inc. common stock, with a stated aggregate market value of $142,100.00 as referenced in the filing.

What share count baseline is given for Delek US Holdings, Inc. (DK) in the Form 144?

The filing states that Delek US Holdings, Inc. had 61,232,174 shares of common stock outstanding, providing a baseline for understanding the relative size of the proposed 2,000-share sale.

When is the proposed sale of Delek US Holdings, Inc. (DK) shares expected under this Form 144?

The notice lists an approximate sale date of August 21, 2026 for the proposed sale of 2,000 shares of Delek US Holdings, Inc. common stock on the NYSE.

How was the Delek US Holdings, Inc. (DK) stock proposed for sale originally acquired?

The filing describes prior open market purchases of 1,000 shares on December 11, 2019 and 1,000 shares on December 30, 2019 for cash, indicating how the securities covered by the notice were acquired.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 02:44 PM EDT Accepted by SEC EDGAR 08/28/2026 - 02:43 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001350103
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Delek US Holdings, Inc.
SEC File Number	001-38142
Address of Issuer	310 SEVEN SPRINGS WAY SUITE 500 BRENTWOOD TENNESSEE 37027
Phone	615-771-6701
Name of Person for Whose Account the Securities are To Be Sold	Marcogliese Richard J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services 184 Liberty Corner Rd, Ste 101 Warren NJ 07059	2000	142100.00	61232174	08/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/11/2019	Open Market Purchase	Open Market			1000	12/11/2019	Cash
Common Stock	12/30/2019	Open Market Purchase	Open Market			1000	12/30/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rich Marcogliese
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)